Anna E. Cartier
Impact in
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Physiology top 10%
- Alzheimer's disease research and treatments
Papers in
-
- Parkinson's Disease Mechanisms and Treatments 3
- Neuroinflammation and Neurodegeneration Mechanisms 1
-
- Neuroscience and Neuropharmacology Research 2
- Co-authors
- Eliezer Masliah (4 shared papers)Iustin V. Tabarean (1 shared paper)Yong Tang (1 shared paper)Subhojit Roy (1 shared paper)Gentry N. Patrick (3 shared papers)Stevan N. Djakovic (1 shared paper)Scott M. Wilson (1 shared paper)Ahmad Salehi (1 shared paper)
- Journals
- Journal of Neuroscience (3 papers)Journal of Nuclear Medicine (1 paper)Alzheimer s & Dementia (1 paper)Experimental Cell Research (1 paper)FEBS Journal (1 paper)
- Partner nations
- United StatesSwedenMexico
In The Last Decade
Anna E. Cartier
8 papers receiving 837 citations
Peers
Comparison fields: 5 of 57
- Neurology 322
- Physiology 210
- Cellular and Molecular Neuroscience 96
- Developmental Neuroscience 9
- Neurology 19
Countries citing papers authored by Anna E. Cartier
This map shows the geographic impact of Anna E. Cartier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna E. Cartier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna E. Cartier more than expected).
Fields of papers citing papers by Anna E. Cartier
This network shows the impact of papers produced by Anna E. Cartier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna E. Cartier. The network helps show where Anna E. Cartier may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna E. Cartier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 288 | |
| 2 | 2010 | 193 | |
| 3 | 2009 | 125 | |
| 4 | 2014 | 72 | |
| 5 | 2012 | 60 | |
| 6 | 2003 | 58 | |
| 7 | 2014 | 50 | |
| 8 | 2020 | 3 |
About Anna E. Cartier
Anna E. Cartier is a scholar working on Neurology, Cellular and Molecular Neuroscience, Neurology, Physiology and Molecular Biology, having authored 8 papers that have together received 849 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (3 papers), Neuroscience and Neuropharmacology Research (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (1 paper), Ubiquitin and proteasome pathways (1 paper), Alzheimer's disease research and treatments (1 paper), Cell death mechanisms and regulation (1 paper) and Herpesvirus Infections and Treatments (1 paper). The work is most often cited by research in Neurology (322 citations), Physiology (210 citations), Cellular and Molecular Neuroscience (96 citations), Developmental Neuroscience (9 citations) and Neurology (19 citations). Anna E. Cartier has collaborated with scholars based in United States, Sweden and Mexico. Frequent co-authors include Eliezer Masliah, Iustin V. Tabarean, Yong Tang, Subhojit Roy, Gentry N. Patrick, Stevan N. Djakovic, Scott M. Wilson, Ahmad Salehi, Kiren K. Ubhi and Tomoaki Komai. Their work appears in journals such as Journal of Neuroscience, Journal of Nuclear Medicine, Alzheimer s & Dementia, Experimental Cell Research and FEBS Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.